seed
Stage
1
Investors
About
Cardiovolt develops AI-powered algorithms to analyze standard 12-lead ECG recordings, extracting digital biomarkers to predict and diagnose multiple cardiovascular diseases with clinical validation across over 5 million ECGs globally.
Explore Cardiovolt's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.